Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

10.57 +0.07 (+0.67%)
Streaming Delayed Price Updated: 11:27 AM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Recent Report Shows That Rep. Debbie Wasserman Schultz Bought Up to $15K Worth of Ichor Holdings Stock
 
Via Benzinga
A Congress Member Sold Up To $30K In AngioDynamics Stock: Here's What You Need To Know
 
Via Benzinga
Why AngioDynamics Stock Popped, Then Dropped Today
AngioDynamics' big Q4 earnings beat wasn't as impressive as it first seemed. 
Via The Motley Fool
Topics Earnings
AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting
AngioDynamics expects a $4 million-$6 million impact from tariffs. Still, it's "profitable," CEO Jim Clemmer says. 
Via Benzinga
Topics World Trade
AngioDynamics (ANGO) Q4 2025 Earnings Transcript
Via The Motley Fool
Topics World Trade
Earnings Outlook For AngioDynamics
 
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics
 
Via Benzinga
4 Analysts Assess AngioDynamics: What You Need To Know
 
Via Benzinga
Earnings Scheduled For July 15, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Get insights into the top gainers and losers of Monday's after-hours session.
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
Gold Moves Higher; US Private Sector Job Growth Tops Estimates
 
Via Benzinga
Traders are paying attention to the gapping stocks in Wednesday's session.
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance
AngioDynamics raised its fiscal 2025 sales outlook to $285M-$288M and boosted its adjusted EBITDA forecast, expecting stronger Med Tech revenue growth. 
Via Benzinga
These stocks are moving in today's pre-market session
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets
The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical... 
Via Stocktwits
Earnings Scheduled For April 2, 2025
 
Via Benzinga
Uncovering Potential: AngioDynamics's Earnings Preview
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
UiPath Posts Weak Revenue, Joins SentinelOne, American Eagle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
Crude Oil Down 1%; US Weekly Jobless Claims Decline
 
Via Benzinga
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Earnings Scheduled For January 8, 2025
 
Via Benzinga
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
Should investors add these stocks on their watchlist? Insider buys suggest so. 
Via Talk Markets
Nasdaq Moves Lower; Levi Strauss Shares Slide
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
 
Via Benzinga
Why AngioDynamics Stock Is Crashing Today
Investors didn't like the medical technology company's fiscal 2025 Q1 update. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.